Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126427741 | 12642774 | 1 | I | 2016 | 20110504 | 20160811 | 20160811 | PER | US-ASTRAZENECA-2011BM07252 | ASTRAZENECA | 77.00 | YR | M | Y | 72.60000 | KG | 20160811 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126427741 | 12642774 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 126427741 | 12642774 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A792143A | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | TID | ||||||
| 126427741 | 12642774 | 3 | C | EXENATIDE 10mcg PEN, DISPOSABLE DEVICE | EXENATIDE | 1 | 0 | SOLUTION FOR INJECTION | |||||||||||
| 126427741 | 12642774 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126427741 | 12642774 | 5 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | UNK | 0 | |||||||||||
| 126427741 | 12642774 | 6 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 126427741 | 12642774 | 7 | C | FEFFIENT | 2 | 0 | |||||||||||||
| 126427741 | 12642774 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 9 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 10 | C | THERMOTABS | 2 | 0 | |||||||||||||
| 126427741 | 12642774 | 11 | C | MONOLUKAST | 2 | 0 | |||||||||||||
| 126427741 | 12642774 | 12 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 13 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 14 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 15 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 16 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 17 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 18 | C | COUMADIN | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 19 | C | LANSOPRZOL | 2 | 0 | |||||||||||||
| 126427741 | 12642774 | 20 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 21 | C | FLOREIAE | 2 | 0 | |||||||||||||
| 126427741 | 12642774 | 22 | C | FINASTERIDE. | FINASTERIDE | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 23 | C | DIAZEBAM | 2 | 0 | |||||||||||||
| 126427741 | 12642774 | 24 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 126427741 | 12642774 | 25 | C | NOVOLOG | INSULIN ASPART | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126427741 | 12642774 | 1 | Type 2 diabetes mellitus |
| 126427741 | 12642774 | 2 | Type 2 diabetes mellitus |
| 126427741 | 12642774 | 7 | Blood disorder |
| 126427741 | 12642774 | 8 | Blood cholesterol increased |
| 126427741 | 12642774 | 9 | Prostatic disorder |
| 126427741 | 12642774 | 10 | Supplementation therapy |
| 126427741 | 12642774 | 13 | Cardiac disorder |
| 126427741 | 12642774 | 14 | Bone disorder |
| 126427741 | 12642774 | 16 | Cardiac disorder |
| 126427741 | 12642774 | 18 | Blood disorder |
| 126427741 | 12642774 | 20 | Gastrooesophageal reflux disease |
| 126427741 | 12642774 | 21 | Ill-defined disorder |
| 126427741 | 12642774 | 24 | Type 2 diabetes mellitus |
| 126427741 | 12642774 | 25 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126427741 | 12642774 | Blood glucose increased | |
| 126427741 | 12642774 | Depression | |
| 126427741 | 12642774 | Drug dose omission | |
| 126427741 | 12642774 | Memory impairment | |
| 126427741 | 12642774 | Off label use | |
| 126427741 | 12642774 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126427741 | 12642774 | 1 | 2006 | 2016 | 0 | |
| 126427741 | 12642774 | 2 | 2016 | 0 |